跳至主要内容
临床试验/JPRN-UMIN000042962
JPRN-UMIN000042962已完成未知

A prospective observational study of immune-related adverse events, treatment efficacy, and pre-existing autoantibodies in patients with small-cell lung cancer who was treated by immune checkpoint inhibitor - Pre-existing autoantibodies and irAE in SCLC patients treated with ICI

Kobe City Medical Center General Hospital Respiratory Medicine0 个研究点目标入组 54 人开始时间: 2021年1月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
54